Pediatric Selective Serotonin Reuptake Inhibitor Toxicity Treatment & Management

  • Author: Mohamed K Badawy, MD, FAAP; Chief Editor: Timothy E Corden, MD   more...
 
Updated: Nov 8, 2011
 

Emergency Department Care

Pay careful attention to the airway, breathing, circulatory, and neurologic parameters. Anticipate airway compromise due to deterioration of mental status, autonomic instability, and neuromuscular dysfunction. Secure the airway if gastric lavage and/or charcoal administration are to be performed in the setting of a decreasing level of consciousness.[9]

Gastric lavage is generally not indicated but may be performed within 60 minutes of suspected ingestion, provided that the airway is secure.

Whole-bowel irrigation may substantially decrease the bioavailability of some ingested drugs; however, data to support or exclude its use in overdoses causing serotonin syndrome are insufficient.

GI decontamination with activated charcoal should be performed, with careful attention to the possibility of impending airway compromise. If progressive deterioration is present, the airway should be secured via endotracheal intubation prior to any decontamination attempts. Nasogastric tube placement may facilitate charcoal administration.

Two large-bore, intravenous catheters should be placed in anticipation of volume and medication administration. Central venous access is necessary in the patient with progressive cardiovascular dysfunction.

Arterial catheter placement is necessary in the patient with progressive cardiovascular dysfunction. An arterial catheter provides continuous arterial pressure monitoring and waveform analysis.

Hemodialysis and hemoperfusion are generally ineffective in enhancing elimination because of the large volume of distribution of SSRIs and should not be routinely used.

Seizures and muscular rigidity are managed best by the use of a benzodiazepine, such as clonazepam or lorazepam.

Most cases resolve within 24-36 hours with supportive care; however, serotonin receptor antagonists may be considered in selected cases (eg, cyproheptadine, chlorpromazine, methysergide, propranolol).

Antihypertensives often are unnecessary unless the hypertension is persistent and clinically significant. If needed, the agent should have a short half-life.

Hyperthermia

Hydration is of utmost importance because of the risks of rhabdomyolysis and possible dehydration from increased insensible water losses due to hyperthermia.

Rhabdomyolysis should be dealt with quickly, with emphasis on maintaining a high urine output combined with alkalinization using sodium bicarbonate (with a target urine pH of 6).

Aggressive cooling may be achieved by removal of clothing, fanning, cooling blankets, spraying of cool water, and intravenous fluids. Mechanical ventilation with proper sedation and paralysis with a nondepolarizing muscle relaxant may be necessary in the setting of life-threatening hyperthermia or rhabdomyolysis.

Continuous monitoring of urine output is indicated if the patient requires vigorous fluid resuscitation, especially in the presence of rhabdomyolysis.

Next

Approach Considerations

Emergency department care in patients with selective serotonin reuptake inhibitor (SSRI) toxicity is mainly supportive,[9] with most cases resolving within 24-36 hours with such care. However, serotonin receptor antagonists may be considered in selected cases (eg, cyproheptadine, chlorpromazine, methysergide, propranolol).

The following consultations are indicated in patients with SSRI toxicity:

  • Pediatric intensivist
  • Toxicologist
  • Psychiatrist
  • Social services specialist

Inpatient care

Frequent assessment of the airway, circulatory, and neurologic parameters is essential in patients with SSRI toxicity. Adequate fluid therapy is critical.

Deterrence and prevention

Patients on SSRIs should consult their physician prior to taking new medications and should be cautioned about the concomitant use of SSRIs and over-the-counter medications without consulting their physician. Examples of common drugs include cold preparations containing dextromethorphan and St. John's Wort, an herbal product. Allow an appropriate washout period of 4-6 weeks between SSRI and monoamine oxidase inhibitor (MAOI) administration.

Previous
Proceed to Medication
 
 
Contributor Information and Disclosures
Author

Mohamed K Badawy, MD, FAAP  Assistant Professor of Emergency Medicine and Pediatrics, University of Texas Southwestern Medical School; Associate Medical Director, Division of Emergency Medicine, Children's Medical Center Dallas

Mohamed K Badawy, MD, FAAP is a member of the following medical societies: Ambulatory Pediatric Association, American Academy of Pediatrics, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Coauthor(s)

Frank Anthony Maffei, MD, FAAP  Associate Professor of Pediatrics, Temple University School of Medicine; Medical Director, Pediatric Intensive Care Unit, Janet Weis Children's Hospital at Geisinger Health System

Frank Anthony Maffei, MD, FAAP is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Chief Editor

Timothy E Corden, MD  Associate Professor of Pediatrics, Co-Director, Policy Core, Injury Research Center, Medical College of Wisconsin; Associate Director, PICU, Children's Hospital of Wisconsin

Timothy E Corden, MD is a member of the following medical societies: American Academy of Pediatrics, Phi Beta Kappa, Society of Critical Care Medicine, and Wisconsin Medical Society

Disclosure: Nothing to disclose.

Additional Contributors

Michael E Mullins, MD Assistant Professor, Department of Emergency Medicine, Washington University School of Medicine

Michael E Mullins, MD is a member of the following medical societies: American Academy of Clinical Toxicology and American College of Emergency Physicians

Disclosure: Johnson & Johnson stock ownership None; Savient Pharmaceuticals stock ownership None

Jeffrey R Tucker, MD Assistant Professor, Department of Pediatrics, Division of Emergency Medicine, University of Connecticut and Connecticut Children's Medical Center

Disclosure: Merck Salary Employment

Mary L Windle, PharmD, Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

References
  1. Schneeweiss S, Patrick AR, Solomon DH, et al. Comparative Safety of Antidepressant Agents for Children and Adolescents Regarding Suicidal Acts. Pediatrics. Apr 12 2010;[Medline].

  2. Hawton K, Bergen H, Simkin S, Cooper J, Waters K, Gunnell D, et al. Toxicity of antidepressants: rates of suicide relative to prescribing and non-fatal overdose. Br J Psychiatry. May 2010;196(5):354-8. [Medline]. [Full Text].

  3. Parks V, Philipp AW, Raje S, Plotka A, Schechter LE, Connell J, et al. Concomitant blockade of 5-HT(1A) receptor and 5-HT transporter: Use of the Hunter Serotonin Toxicity Criteria in a clinical pharmacology study. Eur Neuropsychopharmacol. Jul 4 2011;[Medline].

  4. Gordon JB. SSRIs and St.John's Wort: possible toxicity?. Am Fam Physician. Mar 1 1998;57(5):950,953. [Medline].

  5. Josey ES, Tackett RL. St. John's wort: a new alternative for depression?. Int J Clin Pharmacol Ther. Mar 1999;37(3):111-9. [Medline].

  6. Watson WA, Litovitz TL, Rodgers GC, et al. 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. Sep 2005;23(5):589-666. [Medline].

  7. Sternbach H. The serotonin syndrome. Am J Psychiatry. Jun 1991;148(6):705-13. [Medline].

  8. Attar-Herzberg D, Apel A, Gang N, Dvir D, Mayan H. The serotonin syndrome: initial misdiagnosis. Isr Med Assoc J. Jun 2009;11(6):367-70. [Medline].

  9. [Guideline] Nelson LS, Erdman AR, Booze LL, et al. Selective serotonin reuptake inhibitor poisoning: An evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). May 2007;45(4):315-32. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.